In an unprecedented advancement in cancer treatment, a research team led by Professor Kwang-Hyun Cho from KAIST has developed a groundbreaking technology that targets colon cancer by transforming malignant cells into normal-like cells without killing them. Unlike traditional cancer therapies that
The field of prostate cancer treatment has seen significant advances with the introduction of novel therapies aimed at enhancing patient outcomes. One such promising advancement is the use of gozetotide for the accurate detection of PSMA-positive prostate cancer. This breakthrough is particularly
Multiple myeloma (MM), a complex form of blood cancer originating in plasma cells, relentlessly impairs blood counts and immune functions. Despite breakthroughs in treatment modalities, MM largely remains incurable, with patients often enduring cycles of remission interrupted by relapses. This
The Institute of Cancer Research (ICR) in London is teaming up with Healx, a biotech firm known for its expertise in artificial intelligence (AI) and machine learning, to develop potential new therapies for diffuse intrinsic pontine glioma (DIPG), a rare and currently untreatable form of childhood
In recent years, significant advancements have been made in treating pediatric acute lymphocytic leukemia (B-ALL) through combining traditional chemotherapy with innovative drugs like blinatumomab. This blend of treatments, examined in a clinical trial, has shown promising results, particularly in
Government Funding Bill Removes Pediatric Cancer Research Program In a surprising turn of events, the recent changes in the U.S. government's temporary funding bill have sparked controversy, as funding for pediatric cancer research has been excluded. The new bill, aimed at preventing a government
